No insider purchase over the last 90 days. The latest, by 천종윤, was filed 29 Apr 2026.
Who traded when
BuySaleSince the insiders bought
- +35.4%Entry ₩24,550 · Close 30 Oct 2026 ₩33,250
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- 7,725 sharesKRXDART:20260429000775Canonical exit: 21 Jul 2026 (T+90)
- ●Executives0DART
- 7,468 sharesKRXDART:20260122000322Canonical exit: 19 Apr 2026 (T+90)
- ●Executives0DART
- ShareKRXDART:20240530000929
- 733,532 sharesKRXDART:20230602000327
- 733,532 sharesKRXDART:20230516000199
- 733,532 sharesKRXDART:20230502000712
- ●Executives0DART
- 733,532 sharesKRXDART:20220617000150
- 733,532 sharesKRXDART:20220427000681
- ShareKRXDART:20220427000684
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20220224003952
- ●Executives0DART
- 733,532 sharesKRXDART:20210929000558
- ShareKRXDART:20210827000823
- ShareKRXDART:20210723000345
- ShareKRXDART:20210514000908
- ShareKRXDART:20210430000724
- ShareKRXDART:20210430000740
25 of 62 declarations
About Seegene, Inc.
Selling is the rule at Seegene, Inc. (씨젠), a Korean healthcare company with a market capitalisation of KRW 1,644.9 billion: 50 sales against 2 purchases, or 4% purchases among open-market trades. 최대엽, filed as 전무 (senior managing director), files 42 times, and all 42 are sales, with no purchase. 천종윤 files 10, including 2 purchases and 8 sales. 씨젠 files 6 for its own account, and 김봉호 files 1.
Of 59 filings published between February 25, 2021 and April 29, 2026, 43 date from 2021, against 7 in 2022, 4 in 2023, 1 in each of 2024 and 2025, and 3 in 2026. Most of the record is therefore concentrated in the first year covered. Insiders hold 32.2% of the capital, and 4 filers appear in the record. 7 filings are of another kind.
Read moreShow less
The 3 filings of the last twelve months are 2 purchases and 1 other filing, with no sale. The median publication delay is 7 days, measured on 5 filings.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
